DRIO DarioHealth Corp
Price (delayed)
$0.6297
Market cap
$26.17M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.61
Enterprise value
$28.6M
DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software
Highlights
DarioHealth's gross profit has soared by 122% YoY and by 44% from the previous quarter
DRIO's EPS has soared by 68% year-on-year and by 35% since the previous quarter
The quick ratio has soared by 63% QoQ but it has decreased by 36% YoY
The debt has grown by 2.2% YoY
Key stats
What are the main financial stats of DRIO
Market
Valuations
Earnings
Shares outstanding
41.57M
Market cap
$26.17M
Enterprise value
$28.6M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.3
Price to sales (P/S)
1.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.06
Revenue
$27.04M
Gross profit
$13.27M
Operating income
-$57.74M
Net income
-$42.75M
EBIT
-$44.6M
EBITDA
-$37.17M
Free cash flow
-$38.7M
Per share
Balance sheet
Liquidity
EPS
-$0.61
EPS diluted
-$0.61
Free cash flow per share
-$0.79
Book value per share
$2.11
Revenue per share
$0.55
TBVPS
$0.87
Total assets
$118.88M
Total liabilities
$46.87M
Debt
$30.19M
Equity
$72.02M
Working capital
$23.89M
Debt to equity
0.42
Current ratio
2.44
Quick ratio
2.15
Net debt/EBITDA
-0.07
Margins
Efficiency
Dividend
EBITDA margin
-137.5%
Gross margin
49.1%
Net margin
-158.1%
Operating margin
-213.6%
Return on assets
-33.6%
Return on equity
-59.3%
Return on invested capital
-144.4%
Return on capital employed
-43.6%
Return on sales
-164.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DRIO stock price
How has the DarioHealth stock price performed over time
Intraday
6.69%
1 week
-3.91%
1 month
-9.51%
1 year
-52.65%
YTD
-19.9%
QTD
2.86%
Financial performance
How have DarioHealth's revenue and profit performed over time
Revenue
$27.04M
Gross profit
$13.27M
Operating income
-$57.74M
Net income
-$42.75M
Gross margin
49.1%
Net margin
-158.1%
DarioHealth's gross profit has soared by 122% YoY and by 44% from the previous quarter
The gross margin has soared by 67% YoY and by 23% QoQ
The net margin has grown by 46% YoY and by 23% from the previous quarter
The revenue rose by 33% year-on-year and by 17% since the previous quarter
Growth
What is DarioHealth's growth rate over time
Valuation
What is DarioHealth stock price valuation
P/E
N/A
P/B
0.3
P/S
1.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.06
DRIO's EPS has soared by 68% year-on-year and by 35% since the previous quarter
The P/B is 84% lower than the 5-year quarterly average of 1.7 and 44% lower than the last 4 quarters average of 0.5
DRIO's equity is up by 24% year-on-year and by 23% since the previous quarter
DRIO's P/S is 87% below its 5-year quarterly average of 8.0 and 51% below its last 4 quarters average of 2.2
The revenue rose by 33% year-on-year and by 17% since the previous quarter
Efficiency
How efficient is DarioHealth business performance
DRIO's ROS is up by 43% year-on-year and by 23% since the previous quarter
DRIO's ROA is up by 43% YoY and by 12% QoQ
DarioHealth's return on equity has increased by 35% YoY and by 12% QoQ
The ROIC has grown by 21% YoY and by 9% from the previous quarter
Dividends
What is DRIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DRIO.
Financial health
How did DarioHealth financials performed over time
The total assets is 154% greater than the total liabilities
The quick ratio has soared by 63% QoQ but it has decreased by 36% YoY
DarioHealth's current ratio has soared by 55% from the previous quarter but it has decreased by 36% YoY
The debt is 58% less than the equity
DRIO's equity is up by 24% year-on-year and by 23% since the previous quarter
The company's debt to equity fell by 19% QoQ and by 18% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.